Catalyst Pharmaceuticals Inc expected to post earnings of 42  cents a share - Earnings Preview

Catalyst Pharmaceuticals

08/08/2023 01:38

* Catalyst Pharmaceuticals Inc  CPRX.OQ   CPRX.O  is
expected
to show a rise in quarterly revenue when it reports  results on
August 9. 
    * The Coral Gables Florida-based  company is expected to
report  a
72.7% increase in revenue to $91.706 million from $53.11 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Catalyst
Pharmaceuticals
Inc is for earnings of 42 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Catalyst
Pharmaceuticals Inc is $24​, above​ its last closing price
of $13.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.32        0.32       0.26      Missed  -19.3
 Dec. 31 2023  0.23        0.21       0.22      Beat    3.8
 Sep. 30 2022  0.19        0.19       0.20      Beat    5.3​
 Jun. 30 2022  0.17        0.17       0.20      Beat    17.6
 ​​Mar.        0.14        0.14       0.12      Missed  -11.8
 31 2022                                                
 Dec. 31 2021  0.12        0.12       0.09      Missed  -22.4​
 Sep. 30 2021  0.11        0.10       0.10      Met     -3.8
 Jun. 30 2021  0.10        0.10       0.11      Beat    14.6
 This summary was machine generated August 8 at 00:38 GMT.  All
figures in US dollars  unless otherwise stated